Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jun;33(6):612-614.
doi: 10.1111/tri.13597.

Three is not enough

Christian Morath  1 , Caner Süsal  2
Affiliations
Free article
Comment

Three is not enough

Christian Morath et al. Transpl Int. 2020 Jun.
Free article
No abstract available

PubMed Disclaimer

Comment on

  • Repeated kidney re-transplantation-the Eurotransplant experience: a retrospective multicenter outcome analysis.
    Assfalg V, Selig K, Tolksdorf J, van Meel M, de Vries E, Ramsoebhag AM, Rahmel A, Renders L, Novotny A, Matevossian E, Schneeberger S, Rosenkranz AR, Berlakovich G, Ysebaert D, Knops N, Kuypers D, Weekers L, Muehlfeld A, Rump LC, Hauser I, Pisarski P, Weimer R, Fornara P, Fischer L, Kliem V, Sester U, Stippel D, Arns W, Hau HM, Nitschke M, Hoyer J, Thorban S, Weinmann-Menke J, Heller K, Banas B, Schwenger V, Nadalin S, Lopau K, Hüser N, Heemann U. Assfalg V, et al. Transpl Int. 2020 Jun;33(6):617-631. doi: 10.1111/tri.13569. Epub 2020 Jan 30. Transpl Int. 2020. PMID: 31903658

References

    1. Assfalg V, Selig K, Tolksdorf J, et al. Repeated kidney re-transplantation - the Eurotransplant experience: a retrospective multicentre outcome analysis. Transplant Int 2020; 33: 617.
    1. Redfield RR, Gupta M, Rodriguez E, Wood A, Abt PL, Levine MH. Graft and patient survival outcomes of a third kidney transplant. Transplantation 2015; 99: 416.
    1. Süsal C, Fichtner A, Tönshoff B, Mehrabi A, Zeier M, Morath C. Clinical relevance of HLA antibodies in kidney transplantation: recent data from the Heidelberg Transplant Center and the Collaborative Transplant Study. J Immunol Res 2017; 2017: 1.
    1. Heidt S, Haasnoot GW, Witvliet MD, et al. Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients. Am J Transplant 2019; 19: 2926.

LinkOut - more resources